ARTICLE | Clinical News
Ameluz regulatory update
December 22, 2014 8:00 AM UTC
Swissmedic accepted for review an MAA for Ameluz from Louis Widmer S.A. (Schlieren, Switzerland) to treat actinic keratosis. The photodynamic therapy comprising nanoemulsion BF-200 with 5-aminolevuli...